BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34634673)

  • 1. CircRNA CircZMYM4 inhibits the growth and metastasis of lung adenocarcinoma via the miR-587/ODAM pathway.
    Yuan DF; Wang HR; Wang ZF; Liang GH; Xing WQ; Qin JJ
    Biochem Biophys Res Commun; 2021 Nov; 580():100-106. PubMed ID: 34634673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging.
    Lu T; Qiu T; Han B; Wang Y; Sun X; Qin Y; Liu A; Ge N; Jiao W
    Cell Oncol (Dordr); 2021 Apr; 44(2):297-310. PubMed ID: 33118120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circ-TSPAN4 promotes lung adenocarcinoma metastasis by upregulating ZEB1 via sponging miR-665.
    Ying X; Zhu J; Zhang Y
    Mol Genet Genomic Med; 2019 Dec; 7(12):e991. PubMed ID: 31573758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway.
    Du J; Zhang G; Qiu H; Yu H; Yuan W
    Cell Mol Biol Lett; 2019; 24():72. PubMed ID: 31889960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR-567/PTPRG regulatory pathway.
    Yu C; Tian F; Liu J; Su M; Wu M; Zhu X; Qian W
    Cell Prolif; 2019 May; 52(3):e12610. PubMed ID: 31012177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathway.
    Yao Y; Hua Q; Zhou Y
    Biochem Biophys Res Commun; 2019 Jan; 508(1):37-45. PubMed ID: 30470570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
    Ren P; Hong X; Chang L; Xing L; Zhang H
    Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of circ_0072088/miR-1261/PIK3CA pathway accelerates lung adenocarcinoma progression.
    Cao F; Liu S; Li Z; Meng L; Sang M; Shan B
    Thorac Cancer; 2022 Jun; 13(11):1548-1557. PubMed ID: 35474604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa_circ_0129047 regulates the miR-375/ACVRL1 axis to attenuate the progression of lung adenocarcinoma.
    Fan J; Xia X; Fan Z
    J Clin Lab Anal; 2022 Sep; 36(9):e24591. PubMed ID: 35908770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
    Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
    J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
    Guo H; Li T; Peng C; Mao Q; Shen B; Shi M; Lu H; Xiao T; Yang A; Liu Y
    Hum Exp Toxicol; 2022; 41():9603271221138971. PubMed ID: 36461613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA circABCC4 regulates lung adenocarcinoma progression via miR-3186-3p/TNRC6B axis.
    Liu M; Wang P; Sui X; Ding F; Liu L; Gao Z; Cheng Z
    J Cell Biochem; 2020 Oct; 121(10):4226-4238. PubMed ID: 31960988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.
    Zhu Y; Bo H; Chen Z; Li J; He D; Xiao M; Xiang L; Jin L; Zhou J; Gong L; Zhou Y; Zhou M; Xiong W; Xing X; Li R; Cao K
    Aging (Albany NY); 2020 Nov; 12(21):21904-21922. PubMed ID: 33147570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Regulatory Axis of circ_0008193/miR-1180-3p/TRIM62 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Lung Adenocarcinoma Cells Under Hypoxia.
    Chen M; Huang X; Li L; Huang M; Cai R; Liao X
    Med Sci Monit; 2020 Aug; 26():e922900. PubMed ID: 32782238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.
    Cui Y; Wu X; Jin J; Man W; Li J; Li X; Li Y; Yao H; Zhong R; Chen S; Wu J; Zhu T; Lin Y; Xu J; Wang Y
    Mol Cancer; 2023 Nov; 22(1):179. PubMed ID: 37932766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 18. CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p.
    Zhang SJ; Ma J; Wu JC; Hao ZZ; Zhang YN; Zhang YJ
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3749-3760. PubMed ID: 32329852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ-HMGA2 (hsa_circ_0027446) promotes the metastasis and epithelial-mesenchymal transition of lung adenocarcinoma cells through the miR-1236-3p/ZEB1 axis.
    Yu Z; Zhu X; Li Y; Liang M; Liu M; Liu Z; Qin L; Wu X; Du K; Liu L; Wang Y; Zheng Y
    Cell Death Dis; 2021 Mar; 12(4):313. PubMed ID: 33762580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA GATA6-AS1 upregulates GATA6 to regulate the biological behaviors of lung adenocarcinoma cells.
    Kang H; Ma D; Zhang J; Zhao J; Yang M
    BMC Pulm Med; 2021 May; 21(1):166. PubMed ID: 33992085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.